ER+ Breast Cancer
Oncology
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Preclinical(1)
Frequently asked questions
How many drugs are in development for ER+ Breast Cancer?
BioSniper tracks 1 drug in development for ER+ Breast Cancer across 1 company.
How many clinical trials target ER+ Breast Cancer?
There are 4 clinical trials targeting ER+ Breast Cancer tracked by BioSniper.
What is the prevalence of ER+ Breast Cancer?
The estimated prevalence of ER+ Breast Cancer is approximately 287.0 per 100,000 population.
Deep-dive into ER+ Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis